Startup profile

Fathom Therapeutics

Series ANew York, New York, United States$47M raised

Open roles0
Total raised$47M
Team size1-10
Founded · Stage2023 · Series A

We pull jobs from sources most job seekers never check

Email icon

Get Real-Time Job Alerts For Free

Jobs updated every minute. Get notified for free when new roles matching your interests go live.

No categories available

About the company

What they build and who they serve.

Fathom Therapeutics, formerly Atommap, is a New York-based drug design company combining quantum chemistry, physics-based simulations, and AI to model protein motion at atomic resolution. Its Microcosmos platform generates the data needed to design small molecules with sharper therapeutic effects and reduced off-target risk. The company runs internal discovery programs and discovery partnerships, with a lead asset advanced into animal efficacy studies.

Why it matters

Signals from funding, traction, and product direction.

  • Round was oversubscribed; company rebranded from Atommap Corp. to Fathom Therapeutics alongside the close.
  • Mandana Honu, PhD joined as Chief Business Officer; Diala Ezzeddine, PhD joined the board of directors alongside the financing.
  • Microcosmos platform simulates protein dynamics at atomic resolution; lead program advanced into animal efficacy studies.
  • Microcosmos algorithms accelerate protein dynamics modeling by up to 10,000x without compromising accuracy.
  • Founding/leadership team has collectively advanced 19 drugs to the clinic, including seven FDA-approved medicines.
  • Microcosmos generated potent, selective novel degraders against an undruggable target within six weeks; candidates now being optimized for clinical development.

Funding history

Rounds and investors over time, newest first.

  1. Series A

    $47M
    Sutter Hill Ventures · LeadAlexandria Venture InvestmentsChemistryEmpire State Development's New York Ventures

In the news

Press, announcements, and coverage about this company.

Investors

Sutter Hill VenturesAlexandria Venture InvestmentsChemistryEmpire State Development's New York Ventures

Focus areas

Series AQuantum ComputingBiotechnologyHealthtech
Email alerts

Don’t get beat to tomorrow’s openings

New roles go live every minute and the earliest applicants win. Get the freshest, verified listings delivered straight to your inbox before most job seekers ever see them.

👉 Get free daily job posts